Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 175 publications
Spatially resolved single-cell landscape of tumor immunotypes reveals the central role of interferon signaling and plasmacytoid dendritic cells in triple-negative breast cancer.
Journal: Journal for immunotherapy of cancer
Published: April 20, 2026
Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 16, 2026
Establishment of harmonized international reference ranges for plasma estradiol concentrations in postmenopausal women.
Journal: The Journal of clinical endocrinology and metabolism
Published: January 05, 2026
Reply to: "Rethinking Treatment Priorities in Estrogen Receptor-Low Breast Cancer" and "CDK4/6 Inhibitors in Estrogen Receptor-Low Breast Cancer".
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 28, 2025
Endocrine Therapy Omission in Estrogen Receptor-Low (1%-10%) Early-Stage Breast Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 11, 2025
Adjunctive statistical standardization of quantitated adjuvant HER2 and ultra-low HER2 in Canadian Cancer Trials Group MA.27 trial of exemestane versus anastrozole.
Journal: Breast cancer research and treatment
Published: March 25, 2025
The impact of coadministration of venlafaxine, citalopram or gabapentin on the metabolic activation of tamoxifen.
Journal: Breast cancer research and treatment
Published: December 02, 2024
Evaluation of the androgen receptor in patients with ERα-positive early breast cancer treated with adjuvant tamoxifen ± fluoxymesterone.
Journal: Breast cancer research : BCR
Published: September 19, 2024
Adjunctive Statistical Standardization of Adjuvant Estrogen Receptor and Progesterone Receptor in Canadian Cancer Trials Group MA.27 Postmenopausal Breast Cancer Trial of Exemestane Versus Anastrozole.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 02, 2024
Pre-treatment peripheral blood immunophenotyping and response to neoadjuvant chemotherapy in operable breast cancer.
Journal: Breast cancer research : BCR
Published: February 22, 2024
Last Updated: 09/26/2026